CR1 and systemic sclerosis: To find out if a defective expression of inhibitory receptors could be associated with the B-cell hyperactivity observed in SSc patients, the surface expression of CD22, Siglec 10, CD35, and FcγRIIB was examined on B cells from SSc patients and healthy subjects.